MAPT and Alzheimer disease: Consistent with this hypothesis, the presence of either (1) severe β-amyloid plaque pathology or (2) a cerebrospinal fluid (CSF) AD signature of high phospho-tau/β-amyloid ratio have both been shown to predict a lack of response to shunting8,13.